Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,006 public trials 1,218 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts

NCT01701674

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)

NCT06451042

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Completed

Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma

NCT04566185

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: CHU de Nimes Nîmes, France

View Trial Details

Completed

The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022

NCT07291752

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations: Not specified

View Trial Details

Completed

MIBG for Refractory Neuroblastoma and Pheochromocytoma

NCT01850888

Conditions: Metastatic Pheochromocytoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

NCT04082962

Conditions: Exudative Retinal Detachment and Uveal Melanoma, Eye Diseases, Eye Neoplasms, +12 more
Locations: Anne Marie Lane Boston, Massachusetts, United States

View Trial Details

Completed

EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors

NCT03638167

Conditions: Atypical Teratoid/Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +24 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Completed

Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis

NCT07256184

Conditions: Melanoma, Metastatic Malignant Melanoma, Neoplasms, +10 more
Locations: Ankara Etlik City Hospital Ankara, Yenimahalle, Turkey (Türkiye)

Gazi University, Medical Oncology Department Ankara, Çankaya, Turkey (Türkiye)

View Trial Details

Completed

Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.

NCT04961619

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Novartis Investigative Site Antalya, Konyaalti, Turkey (Türkiye)

Novartis Investigative Site Edirne, Merkez, Turkey (Türkiye)

Novartis Investigative Site Bursa, Nilufer, Turkey (Türkiye)

Novartis Investigative Site Diyarbakır, Sur, Turkey (Türkiye)

View Trial Details

Completed

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01950390

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Kaiser Permanente-Anaheim Anaheim, California, United States

Kaiser Permanente-Baldwin Park Baldwin Park, California, United States

View all 482 locations

View Trial Details